ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,035 | -28.8% | 659,750 | 0.0% | 0.11% | -26.4% |
Q2 2023 | $4,262 | -14.3% | 659,750 | 0.0% | 0.15% | -31.5% |
Q1 2023 | $4,975 | -99.9% | 659,750 | 0.0% | 0.22% | -34.7% |
Q4 2022 | $6,683,268 | +2.4% | 659,750 | 0.0% | 0.33% | -10.5% |
Q3 2022 | $6,525,000 | -7.1% | 659,750 | 0.0% | 0.37% | -27.2% |
Q2 2022 | $7,026,000 | +9.2% | 659,750 | 0.0% | 0.51% | +82.1% |
Q1 2022 | $6,433,000 | -31.8% | 659,750 | 0.0% | 0.28% | -18.4% |
Q4 2021 | $9,434,000 | -28.6% | 659,750 | 0.0% | 0.34% | -20.3% |
Q3 2021 | $13,221,000 | -41.0% | 659,750 | 0.0% | 0.43% | -13.3% |
Q1 2021 | $22,405,000 | -15.6% | 659,750 | 0.0% | 0.50% | -30.8% |
Q4 2020 | $26,548,000 | – | 659,750 | – | 0.72% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DCVC Bio GP, LLC | 29,411 | $313,000 | 100.00% |
Founders Fund VII Management, LLC | 3,773,530 | $40,188,000 | 93.02% |
Gruss & Co., LLC | 363,778 | $3,874,000 | 26.99% |
Founders Fund Growth Management, LLC | 407,017 | $4,334,000 | 12.66% |
GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $44,387,000 | 5.09% |
HARVARD MANAGEMENT CO INC | 4,105,095 | $43,719,000 | 5.06% |
Intellectus Partners, LLC | 1,089,755 | $11,606,000 | 3.99% |
ArchPoint Investors | 630,326 | $6,713,000 | 2.66% |
BRANDYWINE MANAGERS, LLC | 56,976 | $607,000 | 1.49% |
Orbimed Advisors | 4,180,768 | $44,525,000 | 0.81% |